title: The effect of long acting somatostatin analogue SMS 201-995 in acromegaly.
authors.forename: C J
authors.initials: CJ
authors.lastname: Choi
authors.forename: D B
authors.initials: DB
authors.lastname: Shin
authors.forename: S W
authors.initials: SW
authors.lastname: Kim
authors.forename: I M
authors.initials: IM
authors.lastname: Yang
authors.forename: J W
authors.initials: JW
authors.lastname: Kim
authors.forename: Y S
authors.initials: YS
authors.lastname: Kim
authors.forename: Y K
authors.initials: YK
authors.lastname: Choi
mesh_terms: D000172:Acromegaly / Q000188:drug therapy* / Q000503:physiopathology; D000328:Adult; D005260:Female; D005934:Glucagon / Q000378:metabolism; D013006:Growth Hormone / Q000378:metabolism; D006801:Humans; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000627:therapeutic use*; D013973:Thyrotropin-Releasing Hormone / Q000494:pharmacology
chemical_list: D007328:Insulin; D013973:Thyrotropin-Releasing Hormone; D013006:Growth Hormone; D005934:Glucagon; D015282:Octreotide